Cerity Partners LLC Baxter International Inc Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Baxter International Inc stock. As of the latest transaction made, Cerity Partners LLC holds 97,878 shares of BAX stock, worth $3.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

97,878

Previous 82,563 18.55%

Holding current value

$3.19 Million

Previous $2.76 Million 34.59%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$32.85 - $40.26 $503,097 - $616,581	15,315 Added 18.55%	97,878 $3.72 Million
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $567,566 - $751,977	-17,267 Reduced 17.3%	82,563 $2.76 Million
Q1 2024 May 14, 2024	BUY	$37.88 - $43.77 $2.82 Million - $3.26 Million	74,468 Added 293.62%	99,830 $4.27 Million
Q4 2023 Jan 26, 2024	BUY	$31.71 - $38.95 $496,546 - $609,918	15,659 Added 161.38%	25,362 $980,000
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $993,794 - $1.31 Million	-26,629 Reduced 73.29%	9,703 $366,000
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $268,305 - $319,980	6,711 Added 22.66%	36,332 $1.66 Million
Q1 2023 May 11, 2023	BUY	$37.58 - $52.57 $151,297 - $211,646	4,026 Added 15.73%	29,621 $1.2 Million
Q4 2022 Feb 15, 2023	BUY	$49.7 - $57.71 $128,226 - $148,891	2,580 Added 11.21%	25,595 $1.3 Million
Q3 2022 Nov 10, 2022	BUY	$53.86 - $66.8 $38,294 - $47,494	711 Added 3.19%	23,015 $1.24 Million
Q2 2022 Aug 10, 2022	BUY	$63.83 - $80.0 $355,533 - $445,600	5,570 Added 33.29%	22,304 $1.43 Million
Q1 2022 Apr 25, 2022	SELL	$76.85 - $89.45 $191,587 - $222,998	-2,493 Reduced 12.97%	16,734 $1.3 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $454,578 - $531,510	6,096 Added 46.42%	19,227 $1.65 Million
Q3 2021 Oct 25, 2021	SELL	$73.77 - $83.61 $98,704 - $111,870	-1,338 Reduced 9.25%	13,131 $1.06 Million
Q2 2021 Aug 11, 2021	SELL	$80.5 - $88.01 $96,278 - $105,259	-1,196 Reduced 7.63%	14,469 $1.17 Million
Q1 2021 Aug 11, 2021	SELL	$76.38 - $86.03 $88,371 - $99,536	-1,157 Reduced 6.88%	15,665 $1.32 Million
Q1 2021 May 12, 2021	SELL	$76.38 - $86.03 $117,014 - $131,797	-1,532 Reduced 8.35%	16,822 $1.42 Million
Q4 2020 Feb 11, 2021	BUY	$75.39 - $82.36 $112,406 - $122,798	1,491 Added 8.84%	18,354 $1.47 Million
Q3 2020 Nov 12, 2020	BUY	$78.33 - $90.73 $350,526 - $406,016	4,475 Added 36.12%	16,863 $1.36 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $74,176 - $88,774	943 Added 8.24%	12,388 $1.07 Million
Q1 2020 May 14, 2020	SELL	$71.57 - $93.3 $335,878 - $437,856	-4,693 Reduced 29.08%	11,445 $929,000
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $84,983 - $98,002	-1,108 Reduced 6.42%	16,138 $1.35 Million
Q3 2019 Oct 30, 2019	BUY	$81.4 - $89.78 $550,752 - $607,451	6,766 Added 64.56%	17,246 $1.51 Million
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $20,416 - $22,909	-278 Reduced 2.58%	10,480 $858,000
Q1 2019 May 14, 2019	SELL	$64.48 - $81.31 $456,453 - $575,593	-7,079 Reduced 39.69%	10,758 $875,000
Q4 2018 Feb 06, 2019	SELL	$61.45 - $77.8 $3,318 - $4,201	-54 Reduced 0.3%	17,837 $1.17 Million
Q3 2018 Nov 15, 2018	SELL	$70.71 - $77.75 $369,035 - $405,777	-5,219 Reduced 22.58%	17,891 $1.38 Million
Q2 2018 Aug 15, 2018	BUY	$63.43 - $75.41 $321,463 - $382,177	5,068 Added 28.09%	23,110 $1.71 Million
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $234,975 - $271,408	-3,756 Reduced 17.23%	18,042 $1.17 Million
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $619,846 - $666,246	-10,087 Reduced 31.64%	21,798 $1.41 Million
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $1.9 Million - $2.06 Million	31,885	31,885 $2 Million

Others Institutions Holding BAX

# of Institutions

1,006

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Baxter International Inc Transaction History